Bharat Biotech announces DGCI`s approval for its COVAXIN COVID-19 vaccine for Phase I & II human clinical trials - WION 01-Jul-2020

Bharat Biotech announces DGCI`s approval for its COVAXIN COVID-19 vaccine for Phase I & II human clinical trials - WION

Expedited through national regulatory protocols , the company said it accelerated its objective in completing the comprehensive pre-clinical studies and added results from these studies have been promising and show extensive safety and effective immune respon…

More...